Belite Bio, Inc

BLTE · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$31,677$88,157$42,089$17,344
Short-Term Investments$113,472$0$0$0
Receivables$594$867$19$23
Inventory$0$0-$19$0
Other Curr. Assets$1,330$916$718$64
Total Curr. Assets$147,073$89,940$42,807$17,431
Property Plant & Equip (Net)$965$1,301$1,378$94
Goodwill$0$0$0$0
Intangibles$3,991$3,235$31$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$103$166$57$823
Total NC Assets$5,059$4,702$1,466$917
Other Assets$0$0$0$0
Total Assets$152,132$94,642$44,273$18,348
Liabilities
Payables$0$0$0$0
Short-Term Debt$276$616$396$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$5,774$3,017$1,708$1,635
Total Curr. Liab.$6,050$3,633$2,104$1,635
LT Debt$261$578$668$31,806
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$261$578$668$31,806
Other Liabilities$0$0$0$0
Cap. Leases$537$886$866$0
Total Liabilities$6,311$4,211$2,772$33,441
Equity
Pref Stock$0$0$0$0
Common Stock$3$3$3$1
Retained Earnings-$107,647-$71,503-$39,871-$27,223
AOCI-$660-$374-$392-$196
Other Equity$254,125$162,305$81,761$12,325
Total Equity$145,821$90,431$41,501-$15,093
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$152,132$94,642$44,273$18,348
Net Debt-$31,140-$86,963-$41,025$14,462
Belite Bio, Inc (BLTE) Financial Statements & Key Stats | AlphaPilot